2025, Number 1
Efficacy of Probiotics, Prebiotics, and Symbiotics for the Treatment of Depression: A meta-review
Language: English
References: 28
Page: 31-46
PDF size: 314.07 Kb.
ABSTRACT
Background. Recent research has highlighted the importance of nurturing and strengthening the intestinal microbiota due to its relationship with mental health, which has implications for the prevention and management of mental diseases such as depressive disorders. One opportunity to address this is supplementation with live microorganisms called probiotics or substances that promote their development called prebiotics, or both (symbiotics). Objective. This study aims to explore the existing literature on the efficacy of probiotics, prebiotics, and symbiotics for the treatment of depression symptoms and depression. Method. A meta-review of systematic reviews was conducted across various databases (Medline/PubMed, Web of Science, Scopus, Cinahl, and PsycInfo). Formulation of a research question and a comprehensive search strategy employing keywords and Boolean operators guided the identification of systematic reviews reporting quantitative synthesis, particularly meta-analysis of randomized controlled trials (RCT). Systematic reviews meeting these criteria were selected, and relevant findings were systematically extracted. Results. Thirteen systematic reviews with meta-analyses of RCT were selected. The evidence points towards the efficacy of prebiotics, probiotics, and symbiotics in depression treatment, albeit with a weak effect. Conditions optimizing the antidepressant efficacy of these supplements were identified, including their use as adjunctive therapy to pharmacological treatment, concurrent use of probiotics and prebiotics (or symbiotics), and the use of multi-strain formulations. Discussion and conclusion. Prebiotics, probiotics, and symbiotics are considered to demonstrate substantive evidence of their efficacy in the treatment of depression. Nevertheless, various research opportunities within this field have been identified.REFERENCES
Amirani, E., Milajerdi, A., Mirzaei, H., Jamilian, H., Mansournia, M. A., Hallajzadeh,J., & Ghaderi, A. (2020). The effects of probiotic supplementation on mentalhealth, biomarkers of inflammation and oxidative stress in patients withpsychiatric disorders: A systematic review and meta-analysis of randomizedcontrolled trials. Complementary Therapies in Medicine, 49, 102361. https://doi.org/10.1016/j.ctim.2020.102361
Anguiano-Morán, A.C., Díaz de León-Castañeda, C., Rodríguez-Orozco, A.R.,Valtierra-Oba, E.R., Lemus-Loeza, B.M. & Galván-Villalobos, G. (2024).Efficacy of probiotics, prebiotics, and symbiotics for the treatment of depression:a meta-review. Research Registry. Available at: https://www.researchregistry.com/browse-the-registry#registryofsystematicreviewsmeta-analyses/registryofsystematicreviewsmeta-analysesdetails/6610a6af52527e0027e4a05e/
Aromataris, E., Fernandez, R., Godfrey, C. M., Holly, C., Khalil, H., & Tungpunkom,P. (2015). Summarizing systematic reviews: Methodological development,conduct and reporting of an umbrella review approach. International Journalof Evidence-Based Healthcare, 13(3), 132-140. https://doi.org/10.1097/XEB.0000000000000055
Desai, V., Kozyrskyj, A. L., Lau, S., Sanni, O., Dennett, L., Walter, J., & Ospina, M.B. (2021). Effectiveness of Probiotic, Prebiotic, and Synbiotic Supplementationto Improve Perinatal Mental Health in Mothers: A Systematic Review and Meta-Analysis. Frontiers in Psychiatry, 12, https://doi.org/10.3389/fpsyt.2021.622181
El Dib, R., Periyasamy, A. G., de Barros, J. L., França, C. G., Senefonte, F. L.,Vesentini, G., Alves, M. G. O., Rodrigues, J. V. D. S., Gomaa, H., GomesJúnior, J. R., Costa, L. F., Von Ancken, T. D. S., Toneli, C., Suzumura, E. A.,Kawakami, C. P., Faustino, E. G., Jorge, E. C., Almeida, J. D., & Kapoor, A.(2021). Probiotics for the treatment of depression and anxiety: A systematicreview and meta-analysis of randomized controlled trials. Clinical NutritionESPEN, 45, 75-90. https://doi.org/10.1016/j.clnesp.2021.07.027
Halemani, K., Shetty, A. P., Thimmappa, L., Issac, A., Dhiraaj, S., Radha, K., Mishra,P., & Mathias, E. G. (2023). Impact of probiotic on anxiety and depressionsymptoms in pregnant and lactating women and microbiota of infants: Asystematic review and meta-analysis. Journal of Global Health, 13, 4038.https://doi.org/10.7189/jogh.13.04038
Hofmeister, M., Clement, F., Patten, S., Li, J., Dowsett, L. E., Farkas, B., Mastikhina,L., Egunsola, O., Diaz, R., Cooke, N. C., & Taylor, V. H. (2021). The effect ofinterventions targeting gut microbiota on depressive symptoms: a systematicreview and meta-analysis. CMAJ Open, 9(4), E1195-E1204. https://doi.org/10.9778/cmajo.20200283
Page, M. J., McKenzie, J. E., Bossuyt, P. M., Boutron, I., Hoffmann, T. C., Mulrow, C.D., Shamseer, L., Tetzlaff, J. M., Akl, E. A., Brennan, S. E., Chou, R., Glanville,J., Grimshaw, J. M., Hróbjartsson, A., Lalu, M. M., Li, T., Loder, E. W., Mayo-Wilson, E., McDonald, S., McGuinness, L. A., Stewart, L. A., Thomas, J.,Tricco, A. C., Welch, V. A., Whiting, P., & Moher, D. (2021). The PRISMA2020 statement: an updated guideline for reporting systematic reviews. BMJ,n71. https://doi.org/10.1136/bmj.n71
Shea, B. J., Reeves, B. C., Wells, G., Thuku, M., Hamel, C., Moran, J., Moher, D.,Tugwell, P., Welch, V., Kristjansson, E., & Henry, D. A. (2017). AMSTAR 2: acritical appraisal tool for systematic reviews that include randomised or nonrandomisedstudies of healthcare interventions, or both. BMJ, j4008. https://doi.org/10.1136/bmj.j4008